CARDIOLINE

We are driven by a steadfast commitment to pushing the boundaries in Diagnostic Cardiologys and seizing innovation opportunities in healthcare service models.

Our mission is to transform healthcare by leveraging technology and breaking down barriers to make a tangible difference in patient care and advance the field of Diagnostic Cardiology.

With a legacy spanning over five decades, we have consistently been at the forefront of medical technology, delivering state-of-the-art solutions for diagnosing and monitoring cardiac conditions.

Founded in 1962, Cardioline has evolved into a global leader in the design, manufacturing, and distribution of electrocardiography (ECG) devices and other cardiovascular diagnostic equipment, boasting a rich history of pioneering advancements that have revolutionized the healthcare industry.

Today, we are taking yet another significant step forward by introducing an Open Diagnostic Cardiology

Ecosystem, empowering cardiologists and healthcare professionals to work smarter and more efficiently, ultimately improving patient care.

Within this ecosystem, we seamlessly integrate differentiated devices and a cloud-based web app. This integration is designed to streamline data management, optimize workflow efficiencies, and fortify cybersecurity.

The goal is to create a comprehensive and interconnected ecosystem that enhances diagnostic capabilities and patient engagement.

Headquartered in Trento, Italy, Cardioline’s influence extends well beyond Italy, with a strong presence in over 100 countries.

We collaborate with a vast network of distributors, healthcare institutions, and clinicians to make our technology accessible worldwide.

Our commitment to expanding access to high-quality cardiovascular diagnostics has made us a trusted partner in the global healthcare community.